Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global Vaccine Campaign Gains Pace As Brazil Approves Astra Jab

Mon, 18th Jan 2021 05:34

(Alliance News) - The global Covid-19 vaccination drive gained pace Sunday as Brazil gave its first injections and India pushed on with its massive campaign, while European authorities sought to allay concerns about delays in supplies. 

Brazil's health regulator gave the green light for the Oxford-AstraZeneca PLC vaccine and China's CoronaVac to be used as the Latin American giant suffers a devastating second wave of the coronavirus.

Monica Calazans, a 54-year-old intensive care nurse in Sao Paulo became the first person in Brazil to receive the Chinese CoronaVac jab after the Anvisa watchdog's highly anticipated ruling.

Growing concerns over different strains of the virus have meanwhile prompted governments to tighten curbs in a bid to stem a global death toll that has already surpassed two million. 

India's vaccination drive got off to a successful start on Saturday with more than 224,000 people receiving their first jabs and just three people hospitalized after side effects, the health ministry said Sunday.

The government plans to immunise some 300 million people out of its population of 1.3 billion by July – equivalent to almost the entire US population.

In Europe, both France and Russia were gearing up for a key week in the vaccine effort. 

Russia starts mass immunisations on Monday using its home-grown Sputnik V vaccine, while the French government is hoping to overcome fierce criticism of a sluggish rollout as it begins inoculating the over-75s. 

Across the EU there have been concerns that delays in the delivery of the Pfizer Inc-BioNTech SE vaccine could further slow a campaign which critics have condemned as less agile than in the US or Britain, a recently-departed EU member.

US drugmaker Pfizer said it was working to "significantly" scale up production at its plant in Belgium in the second quarter.

After a short delay, deliveries should be back to the original schedule to the EU from January 25. 

"There's a dip," France's Europe minister Clement Beaune told Franceinfo radio.

"But it's better that it happens now when we have stockpiles than when the wider vaccination campaign starts."

Joe Biden's goal of seeing 100 million vaccine doses injected within his first 100 days in office is meanwhile "absolutely" achievable, top US scientist Anthony Fauci said, days before he is to become the new president's chief advisor on Covid-19.

"The feasibility of his goal is absolutely clear, there's no doubt about it," Fauci told NBC's "Meet the Press".

Biden has unveiled a USD1.9 trillion stimulus plan to revive the economy of the country worst-hit by the virus, which has killed more than 397,000 people in the US.

In Israel, the prison service said it would begin vaccinating all inmates, following an outcry over an announcement from Public Security Minister Amir Ohana that Palestinian prisoners would be the last to get inoculated. 

Israel has given at least one vaccine dose to more than two million of its citizens, a pace widely described as the world's fastest per capita.  

Spain has begun administering second doses to people who had already received the first at the end of December, mostly nursing home residents and care staff.

And in Norway, where 13 frail elderly people died after a first vaccine injection, the Medicines Agency said there was no cause for alarm after suggestions last week that the deaths could be linked to side effects.

"It is quite clear that these vaccines present very little risk, with the minimal exception of the most fragile patients," agency official Steinar Madsen told public broadcaster NRK. 

Until vaccination is widespread, countries across the globe are still having to rely on lockdowns, curfews and social distancing to control the spread of the virus – particularly as new variants proliferate.

On Sunday a Belgian elderly care home said that a British strain of the coronavirus, which several studies suggest is up to 70% more contagious, had been detected in 111 residents and staff. Three residents have died. 

Fears over the strain were cited as the justification for Austria's decision to extend its third national lockdown by another two weeks until February 8.

After months of restrictions resentment is growing in some quarters, with around 100 people arrested Sunday at an anti-lockdown protest in Amsterdam.

Police used water cannon to clear the demonstrators, some of whom threw stones at the officers, Amsterdam city hall said in a statement.

Switzerland and Italy are tightening their restrictions from Monday and Britain will require all arrivals to quarantine and show negative tests. Oman meanwhile said it will close its land borders for up to two weeks.

In the world of sports, Australian Open chief Craig Tiley said the Grand Slam tournament will still begin next month, even as 72 players are now confined to their Melbourne hotel rooms for 14 days after coming into contact with Covid-19 cases on their inbound flights.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.